Evidence check: Cardio Risk Check in the context of Wechseljahre

Combining a Cardio Risk Check with menopause context is clinically relevant because estrogen decline during menopause increases cardiovascular risk. Genetic tests can identify variants linked to cholesterol, blood pressure, or inflammation, but effect sizes are small and often not actionable alone. Evidence for genetic-based cardiovascular risk prediction in menopause is moderate at best; traditional risk factors (lipids, blood pressure, lifestyle, family history) and hormonal changes are stronger drivers. MyBody-X may offer a combo test (DNA + biomarkers), but without specific product details, the evidence level is unclear. Caveat: Do not rely solely on genetics. Discuss results with a doctor, especially regarding hormone therapy and lifestyle interventions. The interplay of genes, hormones, and environment is complex.